He manufacturer’s protocol using 18 ml Lipofectamine, 5 mg hTAAR5, 1 mg RTP1S, 0.5 mg Golf, 2 mg pGL4-luciferase and 1 mg pRL-TK-Renilla plasmid for a complete 96-well plate. Eighteen to 24 hours after transfection, cells were stimulated with agonists diluted in CD293 with 2 mM L-glutamine for 4 hours at 37uC. The Dual-Glo Luciferase Assay System (Promega) was used to measure the activation of the transfected TAARs. Renilla luciferase driven by a constitutively active TK-promoterScreening for TMA Anosmics and GenotypingTMA anosmics were Dimethylenastron supplier identified by a forced choice test and solutions for TMA testing were essentially prepared as described by Amoore [19]. Healthy students (age 20?0) were challenged with TMA and two blank probes. Initially identified anosmics were those who failed to recognize TMA two times in a forced choice test. They were retested after 1? days and only anosmics in both tests were considered for further experiments. All TMA anosmics were able to smell pyridine in a concentration of 68 ppm (parts per Felypressin cost million) as a general control. In total, we screened 393 volunteers and identified 12 subjects with specific anosmia confirmed in repeated tests. The identified fraction is smaller than the 7 expected [18], caused by 
the fact that not all initially found anosmics could be retested. Genomic DNA was obtained from the identified TMA anosmics and prepared from buccal swabs with my-Budget Saliva DNA Kit (Bio-Budget Technologies GmbH, Krefeld, Germany) according to the manufacturer’s instructions. TAAR gene sequences were enriched by PCR, using gene specific primers located directly in front of and behind the protein-coding sequence, and purified by agarose gel electrophoresis followed by extraction with the Wizard SV Gel and PCR Clean-Up System (Promega Corporation, Madison, Wisconsin). Purified PCR products were then sequenced by the Ruhr-University Bochum sequencing service using the Applied Biosystems 31306l Genetic Analyzer sequencing setup. Fluorescence flow diagram outputs were viewed and analyzed with the DNASTAR Lasergene SeqMan 
software package.Human TAAR5 Is Activated by TrimethylamineIllumina Sequencing of Control PoolOf the 393 subjects that had been screened for a TMA anosmia, 200 were selected at random to make up the control pool. Their DNA was prepared from buccal swabs using the my-Budget Saliva DNA Kit. DNA concentrations were determined by OD measurement with the NanoDrop ND-1000 spectrophotometer (PEQLAB Biotechnologie GmbH, Erlangen, Germany). Equal amounts (mg) of individuals’ DNAs were pooled into a single sample. From the pooled sample, sequences for the six functional human TAAR genes were enriched by PCR and products were purified by agarose gel electrophoresis and subsequently extracted with the Wizard SV Gel and PCR Clean-Up System. Purified PCR products were pooled into a single sample, which was given to the Cologne Center for Genomics NGS unit, where it was sequenced on the Illumina GAIIx sequencing platform. Raw sequence data was aligned to the human genome reference sequence (hg19) using the 16574785 bowtie algorithm [37] with the “ est”parameter. Output BAM-files were sorted and indexed using the SAMtools software package [38]. Alignments were then scanned for SNPs with the CRISP algorithm (Comprehensive Read analysis for Identification of Single Nucleotide Polymorphisms from Pooled sequencing [20]), using the algorithm’s default parameters for SNP calls. Analysis of the reported SNP frequencies was p.He manufacturer’s protocol using 18 ml Lipofectamine, 5 mg hTAAR5, 1 mg RTP1S, 0.5 mg Golf, 2 mg pGL4-luciferase and 1 mg pRL-TK-Renilla plasmid for a complete 96-well plate. Eighteen to 24 hours after transfection, cells were stimulated with agonists diluted in CD293 with 2 mM L-glutamine for 4 hours at 37uC. The Dual-Glo Luciferase Assay System (Promega) was used to measure the activation of the transfected TAARs. Renilla luciferase driven by a constitutively active TK-promoterScreening for TMA Anosmics and GenotypingTMA anosmics were identified by a forced choice test and solutions for TMA testing were essentially prepared as described by Amoore [19]. Healthy students (age 20?0) were challenged with TMA and two blank probes. Initially identified anosmics were those who failed to recognize TMA two times in a forced choice test. They were retested after 1? days and only anosmics in both tests were considered for further experiments. All TMA anosmics were able to smell pyridine in a concentration of 68 ppm (parts per million) as a general control. In total, we screened 393 volunteers and identified 12 subjects with specific anosmia confirmed in repeated tests. The identified fraction is smaller than the 7 expected [18], caused by the fact that not all initially found anosmics could be retested. Genomic DNA was obtained from the identified TMA anosmics and prepared from buccal swabs with my-Budget Saliva DNA Kit (Bio-Budget Technologies GmbH, Krefeld, Germany) according to the manufacturer’s instructions. TAAR gene sequences were enriched by PCR, using gene specific primers located directly in front of and behind the protein-coding sequence, and purified by agarose gel electrophoresis followed by extraction with the Wizard SV Gel and PCR Clean-Up System (Promega Corporation, Madison, Wisconsin). Purified PCR products were then sequenced by the Ruhr-University Bochum sequencing service using the Applied Biosystems 31306l Genetic Analyzer sequencing setup. Fluorescence flow diagram outputs were viewed and analyzed with the DNASTAR Lasergene SeqMan software package.Human TAAR5 Is Activated by TrimethylamineIllumina Sequencing of Control PoolOf the 393 subjects that had been screened for a TMA anosmia, 200 were selected at random to make up the control pool. Their DNA was prepared from buccal swabs using the my-Budget Saliva DNA Kit. DNA concentrations were determined by OD measurement with the NanoDrop ND-1000 spectrophotometer (PEQLAB Biotechnologie GmbH, Erlangen, Germany). Equal amounts (mg) of individuals’ DNAs were pooled into a single sample. From the pooled sample, sequences for the six functional human TAAR genes were enriched by PCR and products were purified by agarose gel electrophoresis and subsequently extracted with the Wizard SV Gel and PCR Clean-Up System. Purified PCR products were pooled into a single sample, which was given to the Cologne Center for Genomics NGS unit, where it was sequenced on the Illumina GAIIx sequencing platform. Raw sequence data was aligned to the human genome reference sequence (hg19) using the 16574785 bowtie algorithm [37] with the “ est”parameter. Output BAM-files were sorted and indexed using the SAMtools software package [38]. Alignments were then scanned for SNPs with the CRISP algorithm (Comprehensive Read analysis for Identification of Single Nucleotide Polymorphisms from Pooled sequencing [20]), using the algorithm’s default parameters for SNP calls. Analysis of the reported SNP frequencies was p.
